Furthermore, FTO inhibitors have been shown to reduce PI3K and Akt levels in breast cancer cells, leading to decreased activities of pyruvate kinase and hexokinase, thereby inhibiting glycolysis [41]. The gene discussed is FTO; the disease is breast carcinoma.